0.2141
-0.0108
(-4.80%)
At close: January 24 at 4:00:00 PM EST
0.2137
-0.00
(-0.19%)
Pre-Market: 8:47:55 AM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| APPELROUTH STEWART L. Director | Stock Award(Grant) | Dec 31, 2024 | 388,729 |
| BRYAN NANCY K Director | Stock Award(Grant) | Jan 15, 2025 | 139,276 |
| CARTER WILLIAM A Chief Executive Officer | Purchase | Aug 20, 2015 | 1,225,580 |
| EQUELS THOMAS K Chief Executive Officer | Purchase | Dec 18, 2024 | 1,680,700 |
| LINTAL ELLEN M Chief Financial Officer | Stock Award(Grant) | Dec 31, 2019 | 22,892 |
| MITCHELL WILLIAM M Director | Stock Award(Grant) | Dec 31, 2024 | 145,234 |
| PASCALE ADAM Chief Financial Officer | Conversion of Exercise of derivative security | May 8, 2019 | 147,148 |
| RODINO PETER W III Chief Operating Officer | Stock Award(Grant) | Aug 12, 2024 | 401,262 |
| SPRINGATE WAYNE STEVEN Officer | Purchase | Jun 21, 2019 | 8,672 |
| STRAYER DAVID R Officer | Purchase | Jun 21, 2019 | 5,420 |
Related Tickers
IGC IGC Pharma, Inc.
0.3343
-3.41%
BRNS Barinthus Biotherapeutics plc
1.0100
-10.62%
LYEL Lyell Immunopharma, Inc.
0.6050
+3.56%
VINC Vincerx Pharma, Inc.
0.1040
-19.44%
ENVB Enveric Biosciences, Inc.
4.7025
+1,312.16%
BTAI BioXcel Therapeutics, Inc.
0.3400
-10.48%
ERAS Erasca, Inc.
1.9500
-2.01%
LCTX Lineage Cell Therapeutics, Inc.
0.6360
+0.95%
INAB IN8bio, Inc.
0.2750
-4.11%
ATXI Avenue Therapeutics, Inc.
1.8900
+2.72%